Udienza 25 novembre 1876, Pres. Mirabelli P. P., Est. Grimaldi — Angelelli (Avv. Duplessis) c. De Pascalis (Avv. Landolfi)

Publikováno v: Il Foro Italiano, 1877 Jan 01. 2, 337/338-339/340.

Externí odkaz: https://www.jstor.org/stable/23084174

Udienza del 26 giugno 1876, Est. Rossi, P. M. Giannuzzi Savelli — Chiaravalloti (avv. Duplessis), c. Chiaravalloti (avv. Mirabellis)

Publikováno v: Il Foro Italiano, 1876 Jan 01. 1, 849/850-849/850.

Externí odkaz: https://www.jstor.org/stable/23083330

Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.

Autor: Hahn WO; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA., Parks KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Shen M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Janes H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ballweber-Fleming L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Woodward Davis AS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Duplessis C; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Tomai M; 3M Healthcare , St. Paul, MD, USA., Dey AK; International AIDS Vaccine Initiative , New York, NY, USA., Sagawa ZK; Access to Advanced Health Institute , Seattle, WA, USA., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Seese A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kallur Siddaramaiah L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Stamatatos L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Lee WH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Karlinsey D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Rubin V; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Furth S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., MacPhee K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Duff M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Keefer MC; Department of Medicine, University of Rochester, Rochester, NY, USA., Edupuganti S; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Frank I; School of Medicine, University of Pennsylvania , Philadelphia, PA, USA., Maenza J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA., Baden LR; Brigham and Women's Hospital , Boston, MA, USA., Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Sanders RW; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands., Moore JP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA., Tomaras GD; Center for Human Systems Immunology and Departments of Surgery and Integrative Immunobiology, Duke University School of Medicine, Durham, NC, USA., Montefiori DC; Department of Surgery, Duke University, Durham, NC, USA., Rouphael N; Hope Clinic, Emory University , Atlanta, GA, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.

Publikováno v: The Journal of experimental medicine [J Exp Med] 2024 Oct 07; Vol. 221 (10). Date of Electronic Publication: 2024 Sep 05.

Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report.

Autor: Maciel M Jr; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Amara RR; Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA., Bar KJ; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Crotty S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, 92037, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA.; Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, CA, USA., Deeks SG; Department of Medicine, University of California at San Francisco, San Francisco, CA, USA., Duplessis C; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Gaiha G; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., McMichael A; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Palin A; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Rutishauser R; Department of Medicine, University of California, San Francisco, CA, USA., Shapiro S; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., Smiley ST; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA., D'Souza MP; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA. pdsouza@niaid.nih.gov.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Mar 14; Vol. 9 (1), pp. 61. Date of Electronic Publication: 2024 Mar 14.

GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex AR ) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers.

Autor: Duplessis C; Naval Medical Research Command, Silver Spring, MD, USA; Current Affiliation: University of Nevada Reno, Reno, NV, USA., Clarkson KA; Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Current Affiliation: Horizon Therapeutics, Deerfield, IL, USA., Ross Turbyfill K; Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA. Electronic address: Kevin.R.Turbyfill.civ@health.mil., Alcala AN; Naval Medical Research Command, Silver Spring, MD, USA; Current Affiliation: Tigermed-BDM, Somerset, NJ, USA., Gutierrez R; Naval Medical Research Command, Silver Spring, MD, USA; Current Affiliation: Upstate Medical University, Syracuse, NY, USA., Riddle MS; Naval Medical Research Command, Silver Spring, MD, USA; Current Affiliation: University of Nevada Reno, Reno, NV, USA., Lee T; Naval Medical Research Command, Silver Spring, MD, USA., Paolino K; Clinical Trials Center, Division of Translational Medicine, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Current Affiliation: Upstate Medical University, Syracuse, NY, USA., Weerts HP; Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Current Affiliation: National Institute of Allery and Infectious Diseases, Bethesda, MD, USA., Lynen A; Naval Medical Research Command, Silver Spring, MD, USA., Oaks EV; Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Current Affiliation: Patuxent Research and Consulting Group, Gambrills, MD, USA., Porter CK; Naval Medical Research Command, Silver Spring, MD, USA., Kaminski R; Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA; Current Affiliation: Latham BioPharm Group, Cambridge, MA, USA.

Publikováno v: Vaccine [Vaccine] 2023 Oct 06; Vol. 41 (42), pp. 6261-6271. Date of Electronic Publication: 2023 Sep 02.